ArticleClinical and translational medicine2024

Early postoperative plasma circulating tumour DNA for molecular residue disease detection and recurrence risk evaluation in surgical non-small cell lung cancer.

Jie Tang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.